Pharmaceutical and biotechnology companies often recognise that the time comes in a medicine’s lifecycle when the best way to take it forward is to work with a world-class partner.

Sometimes it’s because of a shift in focus. Sometimes it’s a matter of resource. Sometimes it’s capability.
That’s when they need an experienced partner to make sure their asset is available through commercial channels, globally or regionally.

That’s when they need Clinigen.

Key facts

7

Clinigen owned medicines across oncology, immunology and infectious disease

150+

actively marketed licensed products

50+

products commercialised